Bisphenol A Inhibits the Transporter Function of the Blood-Brain Barrier by Directly Interacting with the ABC Transporter Breast Cancer Resistance Protein (BCRP)

Int J Mol Sci. 2021 May 24;22(11):5534. doi: 10.3390/ijms22115534.

Abstract

The breast cancer resistance protein (BCRP) is an important efflux transporter in the blood-brain barrier (BBB), protecting the brain from a wide range of substances. In this study, we investigated if BCRP function is affected by bisphenol A (BPA), a high production volume chemical used in common consumer products, as well as by bisphenol F (BPF) and bisphenol S (BPS), which are used to substitute BPA. We employed a transwell-based in vitro cell model of iPSC-derived brain microvascular endothelial cells, where BCRP function was assessed by measuring the intracellular accumulation of its substrate Hoechst 33342. Additionally, we used in silico modelling to predict if the bisphenols could directly interact with BCRP. Our results showed that BPA significantly inhibits the transport function of BCRP. Additionally, BPA was predicted to bind to the cavity that is targeted by known BCRP inhibitors. Taken together, our findings demonstrate that BPA inhibits BCRP function in vitro, probably by direct interaction with the transporter. This effect might contribute to BPA's known impact on neurodevelopment.

Keywords: ABCG2; BBB; BCRP; BPA; BPF; BPS; bisphenols; blood-brain barrier; breast cancer resistance protein.

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily G, Member 2 / antagonists & inhibitors
  • ATP Binding Cassette Transporter, Subfamily G, Member 2 / chemistry
  • ATP Binding Cassette Transporter, Subfamily G, Member 2 / genetics
  • ATP Binding Cassette Transporter, Subfamily G, Member 2 / metabolism*
  • Benzhydryl Compounds / chemistry
  • Benzhydryl Compounds / pharmacology*
  • Benzhydryl Compounds / toxicity
  • Benzimidazoles / metabolism
  • Blood-Brain Barrier / metabolism*
  • Cell Culture Techniques
  • Cells, Cultured
  • Diketopiperazines / chemistry
  • Diketopiperazines / pharmacology
  • Endothelial Cells / drug effects*
  • Gene Expression
  • Heterocyclic Compounds, 4 or More Rings / chemistry
  • Heterocyclic Compounds, 4 or More Rings / pharmacology
  • Humans
  • In Vitro Techniques
  • Induced Pluripotent Stem Cells / metabolism
  • Molecular Docking Simulation
  • Neoplasm Proteins / antagonists & inhibitors
  • Neoplasm Proteins / chemistry
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / metabolism*
  • Phenols / chemistry
  • Phenols / pharmacology*
  • Phenols / toxicity
  • Protein Binding
  • Sulfones / chemistry
  • Sulfones / pharmacology
  • Sulfones / toxicity

Substances

  • 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester
  • ABCG2 protein, human
  • ATP Binding Cassette Transporter, Subfamily G, Member 2
  • Benzhydryl Compounds
  • Benzimidazoles
  • Diketopiperazines
  • Heterocyclic Compounds, 4 or More Rings
  • Neoplasm Proteins
  • Phenols
  • Sulfones
  • bisphenol F
  • bis(4-hydroxyphenyl)sulfone
  • bisphenol A
  • bisbenzimide ethoxide trihydrochloride